609 related articles for article (PubMed ID: 29697822)
21. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
Cai Y; Guo H; Wang W; Li H; Sun H; Shi B; Zhang Y
Orphanet J Rare Dis; 2018 Mar; 13(1):43. PubMed ID: 29587809
[TBL] [Abstract][Full Text] [Related]
22. Pediatric Renal Angiomyolipomas in Tuberous Sclerosis Complex.
Warncke JC; Brodie KE; Grantham EC; Catarinicchia SP; Tong S; Kondo KL; Cost NG
J Urol; 2017 Feb; 197(2):500-506. PubMed ID: 27678300
[TBL] [Abstract][Full Text] [Related]
23. Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
Krischock L; Beach R; Taylor J
Arch Dis Child; 2010 May; 95(5):391-2. PubMed ID: 20457704
[TBL] [Abstract][Full Text] [Related]
24. Renal manifestations of tuberous sclerosis complex.
O'Hagan AR; Ellsworth R; Secic M; Rothner AD; Brouhard BH
Clin Pediatr (Phila); 1996 Oct; 35(10):483-9. PubMed ID: 8902325
[TBL] [Abstract][Full Text] [Related]
25. Long-term Follow-up Assessing Renal Angiomyolipoma Treatment Patterns, Morbidity, and Mortality: An Observational Study in Tuberous Sclerosis Complex Patients in the Netherlands.
Eijkemans MJ; van der Wal W; Reijnders LJ; Roes KC; van Waalwijk van Doorn-Khosrovani SB; Pelletier C; Magestro M; Zonnenberg B
Am J Kidney Dis; 2015 Oct; 66(4):638-45. PubMed ID: 26165440
[TBL] [Abstract][Full Text] [Related]
26. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
27. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients.
Gupta S; Jimenez RE; Herrera-Hernandez L; Lohse CM; Thompson RH; Boorjian SA; Leibovich BC; Cheville JC
Mayo Clin Proc; 2021 Jun; 96(6):1470-1489. PubMed ID: 33526281
[TBL] [Abstract][Full Text] [Related]
28. Management of renal angiomyolipoma in patients with tuberous sclerosis complex.
Simmons JL; Hussain SA; Riley P; Wallace DM
Oncol Rep; 2003; 10(1):237-41. PubMed ID: 12469175
[TBL] [Abstract][Full Text] [Related]
29. Huge renal angiomyolipomas in tuberous sclerosis complex.
Chan SY; Chan WK
Nephrology (Carlton); 2005 Aug; 10(4):382-6. PubMed ID: 16109086
[TBL] [Abstract][Full Text] [Related]
30. Tuberous sclerosis complex (Bourneville-Pringle disease) in a 25-year- old female with bilateral renal angiomyolipoma and secondary hypertension.
El Aoud S; Frikha F; Snoussi M; Salah RB; Bahloul Z
Saudi J Kidney Dis Transpl; 2017; 28(3):633-638. PubMed ID: 28540905
[TBL] [Abstract][Full Text] [Related]
31. Rates of interventional procedures in patients with tuberous sclerosis complex-related renal angiomyolipoma.
Bissler J; Cappell K; Charles H; Song X; Liu Z; Prestifilippo J; Hulbert J
Curr Med Res Opin; 2015 Aug; 31(8):1501-7. PubMed ID: 26073843
[TBL] [Abstract][Full Text] [Related]
32. Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.
Hatano T; Egawa S
Asian J Surg; 2020 Oct; 43(10):967-972. PubMed ID: 31959574
[TBL] [Abstract][Full Text] [Related]
33. Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization.
Hatano T; Matsu-Ura T; Mori KI; Inaba H; Endo K; Tamari M; Egawa S
Int J Clin Oncol; 2018 Dec; 23(6):1134-1139. PubMed ID: 30069798
[TBL] [Abstract][Full Text] [Related]
34. Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow-up - a questionnaire study.
Cockerell I; Guenin M; Heimdal K; Bjørnvold M; Selmer KK; Rouvière O
BMC Nephrol; 2018 Feb; 19(1):39. PubMed ID: 29439672
[TBL] [Abstract][Full Text] [Related]
35. Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition.
Budde K; Gaedeke J
Am J Kidney Dis; 2012 Feb; 59(2):276-83. PubMed ID: 22130643
[TBL] [Abstract][Full Text] [Related]
36. TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.
Kingswood JC; Bruzzi P; Curatolo P; de Vries PJ; Fladrowski C; Hertzberg C; Jansen AC; Jozwiak S; Nabbout R; Sauter M; Touraine R; O'Callaghan F; Zonnenberg B; Crippa S; Comis S; d'Augères GB; Belousova E; Carter T; Cottin V; Dahlin M; Ferreira JC; Macaya A; Benedik MP; Sander V; Youroukos S; Castellana R; Ulker B; Feucht M
Orphanet J Rare Dis; 2014 Nov; 9():182. PubMed ID: 25424195
[TBL] [Abstract][Full Text] [Related]
37. Symptomatic unilateral renal angiomyolipoma in a child with tuberous sclerosis.
Avolio L; Savasta S; Matteotti C; Fusillo M; Bragheri R
Urol Int; 2001; 67(3):249-51. PubMed ID: 11598456
[TBL] [Abstract][Full Text] [Related]
38. Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies.
Franz DN; Budde K; Kingswood JC; Belousova E; Sparagana S; de Vries PJ; Berkowitz N; Ridolfi A; Bissler JJ
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1796-1803. PubMed ID: 29569806
[TBL] [Abstract][Full Text] [Related]
39. Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
Boggarapu S; Roberds SL; Nakagawa J; Beresford E
Orphanet J Rare Dis; 2022 Sep; 17(1):355. PubMed ID: 36104799
[TBL] [Abstract][Full Text] [Related]
40. Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex.
Tsai JD; Wei CC; Chen SM; Lue KH; Sheu JN
Int Urol Nephrol; 2014 Sep; 46(9):1685-90. PubMed ID: 24682862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
